Carrageenan-Free Diet Shows Improved Glucose Tolerance and Insulin Signaling in Prediabetes: A Randomized, Pilot Clinical Trial

Figure 6

Impact of diet on mononuclear arylsulfatase B and serum galectin-3. (a). Mononuclear ARSB activity (nmol/mg protein/h) was not significantly different between baseline and 12 weeks in the participants on the carrageenan-containing diet (, paired - test, two tailed, and ). (b). In the no-carrageenan diet, the mononuclear ARSB activity increased significantly (, paired -test, two tailed, and ). (c). The changes in mononuclear ARSB activity were different between the carrageenan-free and carrageenan-containing diet groups (, unpaired -test, two tailed, and unequal variance). (d). Serum galectin-3 was similar at 0 and 12 weeks in the carrageenan-containing diet group (, paired -test, two tailed, ). (e). In the carrageenan-free diet group, serum galectin-3 declined significantly between baseline and 12 weeks (, paired -test, two tailed, ). (f). The difference in the change in serum galectin-3 between the two groups was determined (, unpaired -test, two tailed, and unequal variance).

(a)

(b)

(c)

(d)

(e)

(f)